{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-058201","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2025-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.168299+00:00","generated_at":"2026-05-19T15:25:06.019693+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Sagimet amends executive severance agreements with CEO, CFO, and NEO","bullets":["CEO David Happel gets 24 months base salary, target bonus, equity acceleration on change-in-control termination.","CFO Thierry Chauche and NEO Eduardo Martins get 15 months severance under same conditions.","Annual meeting elected Elizabeth Grammer and Beth Seidenberg as Class II directors; ratified Deloitte & Touche as auditor."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-058201","json":"https://secwatch.observer/filing/0001104659-25-058201.json","markdown":"https://secwatch.observer/filing/0001104659-25-058201.md","text":"https://secwatch.observer/filing/0001104659-25-058201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925058201/0001104659-25-058201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000110465925058201/tm2517631d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T15:25:06.019693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}